Welcome Back to the 4th TPD Summit Europe
The 4th TPD Summit Europe returned as Europe’s definitive meeting for uniting Targeted Protein Degradation professionals within Europe and across the globe to explore novel degrader development with new E3 ligase/ligand discovery, overcome safety concerns in PROTACs, and rationally discover molecular glues to deliver clinically approved degraders to high-value targets and patients in need.
Across 3-days, our speaker faculty of 35+ world-class TPD specialists covered end-to-end degrader drug development from novel hit finding, validation, and lead optimisation in our discovery track, to assessing DMPK profiles, measuring efficacy and dose escalation for clinical candidates in our preclinical/clinical track.
Our audience joined a community of 110+ protein degradation professionals at the interface of academia and industry and formed key global connections to deliver a new generation of degraders.
What Was New for 2024?
35+
BRAND NEW SPEAKERS
From across the European TPD landscape & internationally
EXPLORATION
Into HDACs, Lysosomal TPD, and Intramolecular Bivalent Glues
12+
EUROPEAN ACADEMIC INSTITUTIONS
Dedicated to Progressing the Field with Groundbreaking Research
3
REVAMPED WORKSHOPS
Diving into E3 ligase/ligand binding, machine learning & computational approaches, and extracellular assay development for TPD